Google NewsCan IDT Australia (ASX:IDT) Turn Controlled Drugs Into Growth? - Kalkine Media
Can IDT Australia (ASX:IDT) Turn Controlled Drugs Into Growth? Kalkine Media
IDT
Pharmaceuticals, Biotechnology & Life Sciences
IDT Australia
- Short interest
- 0.11%
- +0.10 pp 30d
- as of 21 May 2026
- Reported shorts
- 449.6K
- Shares on issue
- 427.426M
IDT Australia (IDT) News
Latest articles and price-sensitive announcements with AI sentiment classification.
ASX
KalkineIDT Australia Allocates 1,388,545 Shares to Employees via Performance Rights Plan
IDT Australia Limited (ASX:IDT), a pharmaceutical manufacturer based in Boronia, Victoria, has issued 1,388,545 fully paid ordinary shares to its employees following the exercise of Performance Rights. The company submitted a Section 708A Cleansing Notice on 5 October 2026 to validate the share allotment. Key Highlights On 2 October 2026, IDT Australia issued 1,388,545 fully paid ordinary shares to employees upon exercising Performance Rights. The share issuance was conducted under the terms ...
Application for quotation of securities - IDT
other announcement
Why Is IDT Australia (ASX:IDT) Stock Facing Selling Pressure Today? - Kalkine
Why Is IDT Australia (ASX:IDT) Stock Facing Selling Pressure Today? Kalkine
Notification regarding unquoted securities - IDT
other announcement
Application for quotation of securities - IDT
other announcement
Change of Director's Interest Notice - GS
director_dealing announcement
FY26 Appendix 4G and Corporate Governance Statement
other announcement
Change of Director's Interest Notice - JR
director_dealing announcement
Change of Director's Interest Notice - MS
director_dealing announcement
Change of Director's Interest Notice - GS
director_dealing announcement
IDT Australia Limited (ASX:IDT) Drops About 17.07% — What Has Investors Repricing the Pharmaceutical Stock? - Kalkine
IDT Australia Limited (ASX:IDT) Drops About 17.07% — What Has Investors Repricing the Pharmaceutical Stock? Kalkine
Change of Director's Interest Notice - GS
director_dealing announcement
Change of Director's Interest Notice - MS
director_dealing announcement
Change of Director's Interest Notice - MS
director_dealing announcement
Change of Director's Interest Notice - GS
director_dealing announcement
FY25 Appendix 4G and Corporate Governance Statement
other announcement
Agreement with NASDAQ-Listed Gelteq for Dedicated Facility
other announcement
Quarterly Revenue Growth of 30% with $62M in Open Proposals
earnings announcement
Change of Director's Interest Notice - Geoffrey Sam
director_dealing announcement
New $3.2M Contract Supports Australia's Largest API Plant
other announcement
Further Growth in Q2 - H1FY25 Revenue Expected to Jump 82%
earnings announcement